Pharmaceutical composition for treating fecal incontinence
Patent 6635678 Issued on October 21, 2003. Estimated Expiration Date: 
August 24, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
August 24, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesControlled release suppositories Controlled release article with pulsatile release Sustained release suppositories and a process for preparation Patent #: 5436009 InventorsAssigneeApplicationNo. 09/331163 filed on 08/24/1999US Classes:514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/576Benzene ring containingExaminersPrimary: Criares, Theodore J.Assistant: Kim, Jennifer Attorney, Agent or FirmInternational ClassesA61K 31/137 (20060101)A61K 31/223 (20060101) A61K 31/198 (20060101) A61K 31/185 (20060101) A61K 31/21 (20060101) A61K 31/5575 (20060101) A61K 31/00 (20060101) A61K 31/403 (20060101) A61K 31/4045 (20060101) A61K 31/557 (20060101) A61K 31/485 (20060101) Foreign Application Priority Data1996-12-23 GBAbstractFecal incontinence and anal itch can be treated by administration, more particularly by local application to the anus, of an a adrenergic blocker, nitric oxide synthase inhibitor, prostaglandin F2, dopamine, morphine, ଲ-blockers, and 5-Hydroxytryptamine. The patients who benefit most from the invention are those who have a normal or low maximum anal resting pressure and a structurally intact internal anal sphincter muscle, and patients who have had major bowel resection and reanastomisis.Other References
| |
